Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma (Q45423109)

14 December 2017

Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma (English)

1 reference

14 December 2017

1 reference

1 reference

4

1 reference

14 December 2017

Liu J

1

1 reference

14 December 2017

Lian Z

2

1 reference

14 December 2017

Han S

3

1 reference

14 December 2017

Wang H

5

1 reference

14 December 2017

Wu MC

6

1 reference

14 December 2017

Wu K

7

1 reference

14 December 2017

Ding J

8

1 reference

14 December 2017

Arbuthnot P

9

1 reference

14 December 2017

Kew M

10

1 reference

14 December 2017

Fan D

11

1 reference

14 December 2017

Feitelson MA

12

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

14 December 2017

1 reference

14 December 2017

25

1 reference

14 December 2017

7

1 reference

14 December 2017

1008-1017

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209138

14 December 2017

0 references

cites work

Disregulation of E-cadherin in transgenic mouse models of liver cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Genetic mechanisms of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

E-Cadherin Suppresses Cellular Transformation by Inhibiting β-Catenin Signaling in an Adhesion-Independent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

7 January 2021

Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

7 January 2021

The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

7 January 2021

Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

7 January 2021

HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

7 January 2021

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209138

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209138

1 reference

Dimensions Publication ID

14 December 2017

0 references

1 reference